Table 42.
Serovar | Tested for CTX & CAZ | Res to CTX & CAZ | Phenotype | Genotype | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ESBL | AmpC | AmpC + ESBL | Atypical phenotype | ||||||||
N | N | N | % | N | % | N | % | N | % | ||
Chester | 104 | 2 | 0.0 | 2 | 1.9 | DHA‐1 | |||||
Choleraesuis | 5 | 1 | 1 | 20.0 | |||||||
Enteritidis | 1,727 | 3 | 1 | 0.1 | 1 | 0.1 | |||||
Group B | 45 | 2 | 1 | 2.2 | 1 | 2.2 | TEM | ||||
Haifa | 4 | 1 | 1 | 25.0 | SHV‐12 | ||||||
Heidelberg | 7 | 2 | 1 | 14.3 | 1 | 14.3 | CTX‐M‐15; CMY‐2 | ||||
Infantis | 155 | 11 | 9 | 5.8 | CTX‐M‐2 & CTX‐M‐9 (2); CTX‐M‐9 (1) | ||||||
Kentucky | 145 | 2 | 2 | 1.4 | TEM‐15; CTX‐M‐14 | ||||||
Monophasic Typhimurium 1,4,[5],12:i:‐ | 1,043 | 8 | 6 | 0.6 | 1 | 0.1 | SHV‐12; CTX‐M‐9 (2); CMY‐2 | ||||
Newport | 51 | 1 | 1 | 2.0 | CTX‐M‐15 | ||||||
Poona | 13 | 1 | 1 | 7.7 | |||||||
Saintpaul | 16 | 1 | 1 | 6.3 | |||||||
Stanley | 248 | 2 | 1 | 0.4 | 1 | 0.4 | CMY‐2 | ||||
Thompson | 39 | 1 | 1 | 2.6 | CTX‐M‐65 | ||||||
Typhimurium | 862 | 2 | 3 | 0.3 | 1 | 0.1 | 3 | 0.3 | TEM & CTX‐M‐1 | ||
Virchow | 40 | 1 | 1 | 2.5 | SHV |
ESBL: extended‐spectrum beta‐lactamase; N: isolates with this phenotype; %: percentage of isolates with this phenotype from the total tested; CTX: cefotaxime; CAZ: ceftazidime; MSs: Member States.